Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginaton in Diabetic Retinopathy
NCT07236645Phase 2Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Nov 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Vasoclean in diabetic retinopathy (DR), sponsored by Shanghai General Hospital. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
Vasoclean
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT07236645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07236645.